Short-chain regulatory peptides from the Khavinson bioregulator series: organ-specific oligopeptides for research use.
Bioregulators are two-to-four amino acid oligopeptides developed by Professor Vladimir Khavinson, characterised by organ specificity: each compound is derived from a specific tissue and theorised to modulate gene expression within that same tissue type. Key compounds include Epitalon (pineal), Thymalin (thymus), Pinealon (a blood-brain-barrier-penetrating tripeptide), and Cartalax (cartilage), the most studied series of tissue-specific peptide regulators in the gerontological research literature.
Mol. Wt.
432.38 g/mol
Purity
≥98%
CAS No.
N/A (modified Epitalon form)
Mol. Wt.
3,108.31 g/mol
Purity
≥98%
CAS No.
62304-98-7
Mol. Wt.
Variable; peptide fractions 1,000–10,000 Da
Purity
≥98%
CAS No.
N/A (complex polypeptide mixture)
Mol. Wt.
~1,818 g/mol
Purity
≥98%
CAS No.
N/A (novel research peptide)
Khavinson bioregulators are ultra-short synthetic peptides studied for a proposed direct peptide-DNA interaction mechanism and geroprotector effects in preclinical models.
For in-vitro research use only. Not for human or veterinary use.
